Use the Back button in your browser to see the other results of your search or to select another record.
| Prevalence of responders for hepatic fat, adiposity and liver enzyme levels in response to a lifestyle intervention in children with overweight/obesity: EFIGRO randomized controlled trial |
| Medrano M, Arenaza L, Ramirez-Velez R, Ortega FB, Ruiz JR, Labayen I |
| Pediatric Diabetes 2020 Mar;21(2):215-223 |
| clinical trial |
| 4/10 [Eligibility criteria: No; Random allocation: No; Concealed allocation: No; Baseline comparability: Yes; Blind subjects: No; Blind therapists: No; Blind assessors: No; Adequate follow-up: Yes; Intention-to-treat analysis: No; Between-group comparisons: Yes; Point estimates and variability: Yes. Note: Eligibility criteria item does not contribute to total score] *This score has been confirmed* |
|
Copyright release for this abstract has not been granted.
|